Clinical Trial Update: Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases [Phase 2, Phase 3]

View source ↗

Summary

This document notes a Phase 2/3 clinical trial examining IP-001 injected into thermally ablated hepatic tumors in patients with colorectal liver metastases, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastases
• Rectal Cancer

Drugs mentioned

• IP-001 (IP-001)

Snippet

Sponsor: Immunophotonics, Inc. | Conditions: Colorectal Cancer (CRC), Colon Cancer Liver Metastases | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING